Invention Grant
- Patent Title: Modulation of hepatitis B virus (HBV) expression
-
Application No.: US14464449Application Date: 2014-08-20
-
Publication No.: US09127278B2Publication Date: 2015-09-08
- Inventor: Susan M. Freier
- Applicant: Isis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Isis Pharmaceuticals, Inc. Patent Dept.
- Main IPC: C12N15/113
- IPC: C12N15/113
Abstract:
Disclosed herein are antisense compounds and methods for decreasing HBV mRNA, DNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate HBV-related diseases, disorders or conditions.
Public/Granted literature
- US20140357701A1 MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION Public/Granted day:2014-12-04
Information query
IPC分类:
